A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France
Clinical trial NCT04550247 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04550247
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-02
- Primary completion
- 2027-03-15
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.